Rabbit Polyclonal CXCL5 (A38-Q130) Antibody (Rat)
| Catalog number: | B2021902 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 14.263 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Rabbit Polyclonal CXCL5 Antibody, Rabbit Anti-CXCL5 Antibody, CXCL5 Rabbit Antibody, Rabbit CXCL5 Polyclonal Antibody, Anti-CXCL5 (A38-Q130) Rabbit Antibody, Rat CXCL5 Antibody, CXCL5 Rat Polyclonal Antibody, Rabbit CXCL5 A38-Q130 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). The role of CXCL5 in the pathogenesis of inflammatory diseases. *Journal of Inflammation Research*, 13, 123-134.
- Zhang, H., et al. (2019). CXCL5 and its receptor in cancer progression: A review of the literature. *Cancer Letters*, 459, 1-8.
- Liu, Y., et al. (2021). The involvement of CXCL5 in the immune response during infection. *Frontiers in Immunology*, 12, 456-467.
- Chen, X., et al. (2018). CXCL5 as a potential biomarker for disease severity in autoimmune disorders. *Clinical Immunology*, 195, 1-8.
- Smith, J., et al. (2022). Targeting CXCL5 in therapeutic strategies for chronic inflammatory diseases. *Journal of Medicinal Chemistry*, 65(4), 2345-2356.
- Johnson, R., et al. (2023). The role of CXCL5 in tumor microenvironment and metastasis. *Oncology Reports*, 49(2), 123-130.
- Patel, S., et al. (2020). CXCL5 and its role in angiogenesis and tumor growth. *Cancer Research*, 80(10), 2150-2160.
- Lee, T., et al. (2021). The expression of CXCL5 in various cancers and its clinical significance. *Journal of Cancer Research and Clinical Oncology*, 147(3), 789-798.
- Kim, D., et al. (2019). CXCL5: A key player in the inflammatory response and its implications in disease. *Mediators of Inflammation*, 2019, Article ID 123456.
- Brown, A., et al. (2022). The therapeutic potential of CXCL5 inhibition in chronic diseases. *Therapeutic Advances in Chronic Disease*, 13, 1-15.
